🫀 CCTA plaque burden predicted MACE in CAD
🫀 CCTA plaque burden predicted MACE in CAD
In a single-center retrospective study of 381 patients with coronary artery disease undergoing CCTA, AI-quantified total noncalcified plaque burden predicted major adverse cardiovascular events, with 67 patients (17.6%) experiencing MACE over 18 months. The study found total noncalcified percent atheroma volume >4.68% was the strongest predictor (HR 5.073, 95% CI 2.930-8.786), while adding CT-derived fractional flow reserve did not meaningfully improve risk prediction.
Why It Matters To Your Practice
AI-based plaque quantification may help identify higher-risk CAD patients beyond stenosis-focused reads alone.
Noncalcified plaque burden appears more prognostically useful than adding CT-FFR in this dataset.
Risk cutoffs such as total noncalcified percent atheroma volume >4.68% could support more standardized reporting and follow-up decisions.
Clinical Implications
Consider that AI-enabled CCTA analysis may shift attention toward plaque composition and total burden, not just luminal narrowing.
Patients with higher noncalcified plaque burden may warrant closer surveillance, intensified preventive therapy, or cardiology follow-up.
CT-FFR may still have selective value, but this study suggests it did not add clinically meaningful prognostic lift for overall MACE prediction.
Insights
All six total plaque parameters were significantly associated with MACE in univariate analyses.
Among target vessels, RCA plaque burden showed the greatest prognostic weight, though this was exploratory.
MACEs included death, myocardial infarction, heart failure death, malignant arrhythmia, coronary revascularization, and rehospitalization for angina exacerbation.
The Bottom Line
For clinicians tracking how AI may affect practice, this study suggests automated CCTA plaque quantification can add actionable prognostic information in CAD.
The clearest signal was noncalcified plaque burden, while CT-FFR did not significantly improve model performance in this cohort.
Because the study was retrospective and single-center, use these thresholds cautiously until validated externally.